Tolerability and Reactogenicity Trial of the Recombinant Tuberculosis Allergen in Healthy Volunteers
Clinical trial NCT05398562 · COMPLETED
Trial details
- NCT number
- NCT05398562
- Sponsor
- St. Petersburg Research Institute of Vaccines and Sera
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-13
- Primary completion
- 2020-06-17
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.